Valneva SE
Company Profile
Business description
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
Contact
6 Rue Alain Bombard
Saint-Herblain44800
FRAT: +33 228073710
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
713
Stocks News & Analysis
stocks
Ask the analyst: How reliant are Guzman shares on international growth?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,988.00 | 97.20 | 1.09% |
CAC 40 | 7,822.00 | 99.91 | 1.29% |
DAX 40 | 24,370.93 | 361.55 | 1.51% |
Dow JONES (US) | 44,484.49 | 229.71 | 0.52% |
FTSE 100 | 8,972.64 | 46.09 | 0.52% |
HKSE | 24,716.28 | 217.33 | 0.89% |
NASDAQ | 20,885.65 | 155.16 | 0.75% |
Nikkei 225 | 39,778.85 | 122.34 | -0.31% |
NZX 50 Index | 12,895.40 | 10.01 | -0.08% |
S&P 500 | 6,297.36 | 33.66 | 0.54% |
S&P/ASX 200 | 8,737.70 | 98.70 | 1.14% |
SSE Composite Index | 3,528.66 | 11.83 | 0.34% |